AVBP as of Nov 3 · 13:03 ET

AVBPNasdaqPharmaceutical Preparations

ArriVent BioPharma, Inc. · Brief

Next report

6 days

Nov 9 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±20.7%implied · report alone

10.5816.12

straddle ±23.7%

spot 13.35exp Nov 20ATM strike 12.5ATM straddle 3.73IV 161%

Nov 2 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

0 of 6≥ implied

avg implied: ±20.1%
avg realized: ±3.2%

Nov 14 '24—▼−11.86%—

Mar 3 '25—▼−6.69%—

May 12 '25±21.4%▼−0.79%×0.04

Aug 11 '25±24.7%▼−3.34%×0.14

Nov 10 '25±21.0%▲+3.08%×0.15

Q1 FY26±25.8%▼−7.21%×0.28

May 11 '26±11.3%▼−0.17%×0.01

Q2 FY26±16.3%▼−4.64%×0.29

quarterimplied−30%0+30%realized×

Q2 FY26±16.3%▼−4.64%×0.29

May '26±11.3%▼−0.17%×0.01

Q1 FY26±25.8%▼−7.21%×0.28

Nov '25±21.0%▲+3.08%×0.15

Aug '25±24.7%▼−3.34%×0.14

May '25±21.4%▼−0.79%×0.04

2 older reports

Mar '25—▼−6.69%—

Nov '24—▼−11.86%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 4

8disclosed supplier and customer ties in SEC filingsSEC filings

4tracked funds holding AVBPN-PORT · Aug 31 '26

Bear2 of 4

6 of 6recent reports where the move came in under the options implied rangeEarnings history

0.28%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

AVBP report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 26impliedImplied move: ±26.0% into Nov 9 earnings (Oct 26 close).Source

Oct 6haltTrading halt: 07:55 ET, resumed 08:20 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.